CADTH is committed to supporting Canada’s health care decision-makers through this challenging and uncertain time.
For evidence, tools, and resources related to COVID-19, visit our COVID-19 Evidence Portal.

 

Begin main content

Nabilone for the Treatment of Nausea and Vomiting, or Anorexia: Clinical Effectiveness and Guidelines – An Update

Last updated: October 22, 2018
Project Number: RA0973-000
Product Line: Rapid Response
Research Type: Drug
Report Type: Reference List
Result type: Report

Question

  1. What is the clinical effectiveness of nabilone for the treatment of nausea and vomiting, or anorexia in adults and adolescents?
  2. What are the evidence-based guidelines associated with the use of nabilone for the treatment of nausea and vomiting, or anorexia in adults and adolescents?

Key Message

One systematic review and three randomized controlled trials were identified regarding the clinical effectiveness of nabilone for the treatment of nausea and vomiting, or anorexia in adults and adolescents. No evidence-based guidelines were identified.